Levi & Korsinsky Announces Lawsuit Against Telix Pharmaceuticals, Sets January 9, 2026 Deadline for Shareholder Claims
NEW YORK, NY - January 2, 2026 – Levi & Korsinsky, LLP, a nationally recognized securities litigation firm, today announced teh filing of a class action lawsuit against Telix Pharmaceuticals Ltd. (TLX) and is notifying investors of a January 9, 2026 deadline to participate in the litigation. The lawsuit seeks to recover losses sustained by shareholders between February 21, 2025, and August 28, 2025.
The suit alleges that Telix pharmaceuticals made false and misleading statements concerning its buisness operations and prospects, ultimately harming investors. Specifically,the complaint claims defendants materially overstated the progress of prostate cancer therapeutic candidates,misrepresented the quality of their supply chain and partnerships,and lacked a reasonable basis for their statements regarding the company’s business.
Shareholders who purchased Telix Pharmaceuticals Ltd. stock during the specified period are encouraged to visit https://zlk.com/pslra-1/telix-pharmaceuticals-ltd-lawsuit-submission-form?prid=179329&wire=1&utm_campaign=15 to learn more about their rights and potential recovery options. Participation in the lawsuit is offered at no cost or obligation.
Levi & Korsinsky has a proven track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years. The firm consistently ranks among the top securities litigation firms in the United States, appearing in ISS Securities Class Action Services’ Top 50 Report for seven consecutive years.
Investors with questions are invited to contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or call (212) 363-7500.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
https://zlk.com/
SOURCE: Levi & Korsinsky, LLP
